Trial Profile
Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Pyrazinamide; Rifampicin
- Indications Acute pain; Ankylosing spondylitis; Back pain; Cervicobrachial syndrome; Dysmenorrhoea; Familial adenomatous polyposis; Juvenile rheumatoid arthritis; Osteoarthritis; Pain; Periarthritis; Postoperative pain; Rheumatoid arthritis; Tendinitis; Tenosynovitis
- Focus Pharmacokinetics
- 12 Apr 2017 Status changed from recruiting to completed.
- 17 Nov 2015 New trial record